Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 1,199 | 1,189 | 1,261 | 0 | 1,158 |
| Cost of Goods | 1,132 | 1,162 | 1,178 | N/A | 1,103 |
| Gross Profit | 67 | 27 | 83 | N/A | 55 |
| Operating Expenses | 1,526 | -1,000 | 1,352 | 0 | 1,209 |
| Operating Income | -1,327 | -1,410 | -1,091 | N/A | -1,051 |
| Other Income | 132 | 99 | 71 | 0 | 98 |
| Pre-tax Income | -1,195 | -1,311 | -1,020 | 0 | -954 |
| Net Income Continuous | -1,195 | N/A | -1,020 | N/A | -954 |
| Net Income | $-1,195 | $N/A | $-1,020 | $N/A | $-954 |
| EPS Basic Total Ops | -0.20 | -0.20 | -0.20 | N/A | -0.20 |
| EPS Basic Continuous Ops | -0.22 | N/A | -0.19 | N/A | -0.17 |
| EPS Diluted Total Ops | -0.20 | -0.20 | -0.20 | N/A | -0.20 |
| EPS Diluted Continuous Ops | -0.22 | N/A | -0.19 | N/A | -0.17 |
| EBITDA(a) | $-824 | $1,376 | $-1,091 | $N/A | $-517 |